Details
Structure visualisation
Entry information
| Complex | |
| AACDB_ID: | 159 |
| PDBID: | 1S78 |
| Chains: | FE_B |
| Organism: | Homo sapiens, Mus musculus |
| Method: | XRD |
| Resolution (Å): | 3.25 |
| Reference: | 10.1016/s1535-6108(04)00083-2 |
| Antibody | |
| Antibody: | Pertuzumab Fab |
| Antibody mutation: | No |
| INN (Clinical Trial): | Pertuzumab(Approved) |
| Antigen | |
| Antigen: | Receptor protein-tyrosine kinase erbB-2 |
| Antigen mutation: | No |
| Durg Target: | P04626 |
Sequence information
Antibody
Heavy Chain: F
Mutation: NULL
| >1S78_F|Chain D, F|Pertuzumab Fab heavy chain|Mus musculus (10090) EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH |
Light Chain: E
Mutation: NULL
| >1S78_E|Chain C, E|Pertuzumab Fab light chain|Mus musculus (10090) DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
Antigen
Chain: B
Mutation: NULL
| >1S78_B|Chain A, B|Receptor protein-tyrosine kinase erbB-2|Homo sapiens (9606) TQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQ |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
| E: ILE31 TYR49 SER50 TYR53 TYR55 THR56 TYR94 F: THR28 THR30 ASP31 TYR32 THR33 PRO52 ASN53 SER54 GLY55 GLY56 SER57 ILE58 TYR59 GLN61 LYS64 VAL71 ARG73 SER74 LYS75 ARG94 LEU96 GLY97 PRO98 TYR99 ASP101 B: LYS128 GLN156 HIS235 PHE236 LEU244 HIS245 CYS246 ALA248 TYR252 THR254 ASP255 THR256 PHE257 THR268 GLY270 THR284 ASP285 VAL286 GLY287 SER288 THR290 VAL292 PRO294 LEU295 HIS296 ASN297 LYS311 SER313 LYS314 PRO315 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)
